6533b838fe1ef96bd12a48d5

RESEARCH PRODUCT

Recovery from Toxic-Induced Demyelination Does Not Require the NG2 Proteoglycan

Jacqueline TrotterClaudia KemmingStefanie AlbrechtTanja KuhlmannKarin HagemeierMarc Ehrlich

subject

0301 basic medicineReceptor Platelet-Derived Growth Factor alphaCellular differentiationlcsh:MedicineGene ExpressionMice TransgenicOLIG203 medical and health scienceschemistry.chemical_compoundCuprizone0302 clinical medicineCell MovementExtracellularmedicineAnimalsRemyelinationAntigenslcsh:ScienceCells CulturedCell ProliferationMice KnockoutMultidisciplinarybiologyMicrogliaReverse Transcriptase Polymerase Chain ReactionStem Cellslcsh:RBrainCorrectionCell DifferentiationImmunohistochemistryCell biologyMicroscopy ElectronOligodendroglia030104 developmental biologymedicine.anatomical_structurenervous systemchemistryChondroitin sulfate proteoglycanCell cultureImmunologybiology.proteinlcsh:QProteoglycans030217 neurology & neurosurgeryPlatelet-derived growth factor receptorDemyelinating Diseases

description

NG2 cells are defined as CNS cells expressing chondroitin sulfate proteoglycan nerve/glia antigen. The vast majority of NG2-positive cells also express platelet-derived growth factor receptor alpha (PDGFRα) and are oligodendroglial progenitors (OPC). In addition a subpopulation of pericytes expresses NG2, but is positive for PDGF receptor beta (PDGFRβ) [1]. NG2-positive OPC comprise approximately 5% of the cells in the CNS where they are evenly distributed in grey and white matter [2, 3]. NG2-positive OPC form synapses with neurons [4–6] and react to brain injury with proliferation, as has been shown in several animal models as well as in human demyelinating and degenerative diseases [7–9]. In vitro, NG2 positive cells can give rise to oligodendrocytes, astrocytes and occasional neurons depending on cell culture conditions [10–12]. In vivo, NG2 cells generate mostly oligodendrocytes as well as small populations of astrocytes as has been demonstrated in fate mapping studies [9, 13–16]. The developmental fate switch from the oligodendroglial into the astrocytic lineage is regulated by Olig2 [17]. A large percentage of NG2 positive cells persists as a self-renewing population in the adult CNS [18–21]. Although NG2 has been extensively used as a marker for OPC, relatively little is known about the functional role of the NG2 proteoglycan. NG2 consists of a small intracellular and a large extracellular domain. The extracellular domain is cleaved by proteases such as ADAM 10 in an activity-dependent fashion, which regulates glutamate signalling at nearby neurons. The NG2 extracellular domain binds receptors, growth factors, extracellular matrix components and proteases (for review see [22, 23]). Lack of NG2 expression in NG2 deficient (NG2-/-) mice or pharmacological inhibition of NG2 ectodomain shedding in wild type OPC results in NMDA and AMPA receptor-dependent reduction of neuronal current amplitudes and an altered behaviour of NG2-/- mice in tests measuring sensorimotor function. These results demonstrate a bidirectional cross-talk between OPC and the surrounding neuronal network [24, 25]. The intracellular domain can be cleaved by the gamma-secretase and may influence the expression of genes, such as prostaglandin D2 synthase which has neuromodulatory properties [26]. NG2 has been reported to promote migration and proliferation in oligodendroglial and neoplastic glioma cells [27–30]. In OPC the effect on migration is mediated via modulation of Rho GTPases and RAC activity and an influence on cell polarity via selective subcellular localization [31, 32]. Contradictory results have been published with respect to the effect of NG2 on de- and remyelination, as well as on inflammation in inflammatory and/or demyelinating animal models. Mice lacking NG2 were reported to show reduced inflammation as well as reduced myelin damage and repair after injection of lysolecithin [33]. In contrast, in EAE experiments using this same NG2-/- mouse line [34] no differences in disease course or extent of de- and remyelination or inflammation was observed [35]. We hypothesized that the effect of a lack of NG2 might be amplified by extended time periods of demyelination. Furthermore, the initial NG2-/- mouse line [34] was generated by insertion of a neo cassette that may affect the function of nearby genes. We thus utilized mice lacking NG2 in which eYFP was inserted in the endogenous NG2 locus [36]. When bred to homozygosity these mice lack expression of NG2. We fed homozygous NG2-/- mice and their wild type littermates (NG2+/+) for 10 weeks with the copper chelator cuprizone which leads to oligodendroglial death and compared the extent of de- and remyelination as well as the degree of inflammation as measured by the numbers of Mac3 (+) microglia/macrophages. In addition, we isolated OPC from NG2-/- as well NG2+/+ mice to compare and analyze oligodendroglial properties prerequisite for remyelination, namely proliferation, migration and differentiation. In vitro, NG2-/- OPC demonstrated an increased migratory capacity in PDGF-AA, but not FGF-elicited chemotaxis; however lack of NG2 did not affect proliferation or differentiation of isolated OPC. No effect of NG2 deficiency on de- or remyelination, numbers of myelinated axons, oligodendrocytes or microglia/macrophages was observed.

10.1371/journal.pone.0163841https://pubmed.ncbi.nlm.nih.gov/29518167